ArticleHepatology international2024

CBX1 is involved in hepatocellular carcinoma progression and resistance to sorafenib and lenvatinib via IGF-1R/AKT/SNAIL signaling pathway.

Su-Su Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.